Literature DB >> 1448886

Ultrastructural and immunocytochemical study of a primary gastrinoma of the liver.

J Larriva-Sahd1, A Angeles-Angeles, R Hernández-Pando, L Muñoz Fernández, A Rondán, H Orozco Estévez, M Campuzano Fernández.   

Abstract

A primary hepatic gastrinoma found in a 13-year-old boy was studied by light microscopy, immunohistochemistry, electron microscopy, and immunoelectron microscopy. Results were consistent with a neuroendocrine neoplasm with abundant gastrin-immunoreactive cells. Unlike all previously reported cases of primary hepatic neuroendocrine tumors, which have been endocrinologically asymptomatic, the patient had a Zollinger-Ellison syndrome apparently cured by surgical resection of the tumor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1448886     DOI: 10.3109/01913129209023756

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  5 in total

1.  Primary calcified gastrinoma of the liver.

Authors:  R N Chien; T C Chen; C T Chiu; S L Tsai; L B Jen; Y F Liaw
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

2.  Diagnosis and surgical treatment for primary liver gastrinoma: report of a case.

Authors:  Chikashi Shibata; Hiroo Naito; Yuji Funayama; Kouhei Fukushima; Ken-Ichi Takahashi; Michiaki Unno; Iwao Sasaki
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

3.  [Primary neuroendocrine carcinoma of the liver. From carcinoid tumor to small-cell hepatic carcinoma: case reports and review of the literature].

Authors:  Z Balta; T Sauerbruch; A Hirner; R Büttner; H-P Fischer
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

4.  Primary hepatic carcinoid tumours.

Authors:  M Nikfarjam; V Muralidharan; C Christophi
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

5.  Primary hepatic gastrinoma causing zollinger-ellison syndrome: a rare and challenging diagnosis.

Authors:  Adrian Harvey; Janice L Pasieka; Hassan Al-Bisher; Elijah Dixon
Journal:  Cancers (Basel)       Date:  2012-02-14       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.